188 related articles for article (PubMed ID: 8457221)
1. Cancer in systemic sclerosis.
Abu-Shakra M; Guillemin F; Lee P
Arthritis Rheum; 1993 Apr; 36(4):460-4. PubMed ID: 8457221
[TBL] [Abstract][Full Text] [Related]
2. [Cancers in systemic sclerosis : risk factors, impact on survival and literature review].
Catano J; Guedon A; Riviere S; Carrat F; Mahevas T; Fain O; Mekinian A
Rev Med Interne; 2019 Oct; 40(10):637-644. PubMed ID: 31255252
[TBL] [Abstract][Full Text] [Related]
3. Incidence and the risk factor of malignancy in Japanese patients with systemic sclerosis.
Hashimoto A; Arinuma Y; Nagai T; Tanaka S; Matsui T; Tohma S; Endo H; Hirohata S
Intern Med; 2012; 51(13):1683-8. PubMed ID: 22790126
[TBL] [Abstract][Full Text] [Related]
4. Cancer risk among patients with systemic sclerosis: a nationwide population study in Taiwan.
Kuo CF; Luo SF; Yu KH; Chou IJ; Tseng WY; Chang HC; Fang YF; Chiou MJ; See LC
Scand J Rheumatol; 2012 Feb; 41(1):44-9. PubMed ID: 22150162
[TBL] [Abstract][Full Text] [Related]
5. Incidence of cancer among patients with systemic sclerosis in Korea: results from a single centre.
Kang KY; Yim HW; Kim IJ; Yoon JU; Ju JH; Kim HY; Park SH
Scand J Rheumatol; 2009; 38(4):299-303. PubMed ID: 19308805
[TBL] [Abstract][Full Text] [Related]
6. Malignancy in systemic lupus erythematosus.
Abu-Shakra M; Gladman DD; Urowitz MB
Arthritis Rheum; 1996 Jun; 39(6):1050-4. PubMed ID: 8651970
[TBL] [Abstract][Full Text] [Related]
7. Systemic sclerosis and malignancy: a review of the literature.
Wooten M
South Med J; 2008 Jan; 101(1):59-62. PubMed ID: 18176294
[TBL] [Abstract][Full Text] [Related]
8. Incidence, Risk Factors, and Outcomes of Cancer in Systemic Sclerosis.
Morrisroe K; Hansen D; Huq M; Stevens W; Sahhar J; Ngian GS; Ferdowsi N; Hill C; Roddy J; Walker J; Proudman S; Nikpour M
Arthritis Care Res (Hoboken); 2020 Nov; 72(11):1625-1635. PubMed ID: 31539207
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer in systemic sclerosis: results of a cross-linkage of an Italian Rheumatologic Center and a population-based Cancer Registry and review of the literature.
Colaci M; Giuggioli D; Vacchi C; Lumetti F; Iachetta F; Marcheselli L; Federico M; Ferri C
Autoimmun Rev; 2014 Feb; 13(2):132-7. PubMed ID: 24103404
[TBL] [Abstract][Full Text] [Related]
10. Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature.
Colaci M; Giuggioli D; Sebastiani M; Manfredi A; Vacchi C; Spagnolo P; Cerri S; Luppi F; Richeldi L; Ferri C
Autoimmun Rev; 2013 Jan; 12(3):374-9. PubMed ID: 22743031
[TBL] [Abstract][Full Text] [Related]
11. Incidence of lung cancer in patients with systemic sclerosis treated with extracorporeal photopheresis.
Topuzoglu S; Knobler R; Movadat O; Petkov V; Foedinger D; Just U; Pehamberger H; Jantschitsch C
Photodermatol Photoimmunol Photomed; 2015 Jul; 31(4):175-83. PubMed ID: 25495608
[TBL] [Abstract][Full Text] [Related]
12. Determinants of morbidity and mortality of systemic sclerosis in Canada.
Al-Dhaher FF; Pope JE; Ouimet JM
Semin Arthritis Rheum; 2010 Feb; 39(4):269-77. PubMed ID: 18706680
[TBL] [Abstract][Full Text] [Related]
13. Cancer incidence in systemic sclerosis: meta-analysis of population-based cohort studies.
Onishi A; Sugiyama D; Kumagai S; Morinobu A
Arthritis Rheum; 2013 Jul; 65(7):1913-21. PubMed ID: 23576072
[TBL] [Abstract][Full Text] [Related]
14. Standardized incidence ratios and risk factors for cancer in patients with systemic sclerosis: Data from the Spanish Scleroderma Registry (RESCLE).
Carbonell C; Marcos M; Guillén-Del-Castillo A; Rubio-Rivas M; Argibay A; Marín-Ballvé A; Rodríguez-Pintó I; Baldà-Masmiquel M; Callejas-Moraga E; Colunga D; Sáez-Comet L; González-Echávarri C; Ortego-Centeno N; Marí-Alfonso B; Vargas-Hitos JA; Todolí-Parra JA; Trapiella L; Herranz-Marín MT; Freire M; Castro-Salomó A; Perales-Fraile I; Madroñero-Vuelta AB; Sánchez-García ME; Ruiz-Muñoz M; González-García A; Sánchez-Redondo J; de-la-Red-Bellvis G; Fernández-Luque A; Muela-Molinero A; Lledó GM; Tolosa-Vilella C; Fonollosa-Pla V; Chamorro AJ; Simeón-Aznar CP;
Autoimmun Rev; 2022 Oct; 21(10):103167. PubMed ID: 35931315
[TBL] [Abstract][Full Text] [Related]
15. Increased malignancies in our Waikato cohort of patients with systemic sclerosis.
Rees MS; Frampton C; White DHN; Solanki KK
Int J Rheum Dis; 2021 Apr; 24(4):555-561. PubMed ID: 33751804
[TBL] [Abstract][Full Text] [Related]
16. A cohort study of cancer incidence in systemic sclerosis.
Derk CT; Rasheed M; Artlett CM; Jimenez SA
J Rheumatol; 2006 Jun; 33(6):1113-6. PubMed ID: 16622904
[TBL] [Abstract][Full Text] [Related]
17. Incidence of lung cancer in systemic sclerosis.
Peters-Golden M; Wise RA; Hochberg M; Stevens MB; Wigley FM
J Rheumatol; 1985 Dec; 12(6):1136-9. PubMed ID: 4093920
[TBL] [Abstract][Full Text] [Related]
18. Malignancies associated with systemic sclerosis.
Szekanecz É; Szamosi S; Horváth Á; Németh Á; Juhász B; Szántó J; Szücs G; Szekanecz Z
Autoimmun Rev; 2012 Oct; 11(12):852-5. PubMed ID: 22410174
[TBL] [Abstract][Full Text] [Related]
19. Cancer and systemic sclerosis. An epidemiologic study.
Roumm AD; Medsger TA
Arthritis Rheum; 1985 Dec; 28(12):1336-40. PubMed ID: 4084328
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for lung cancer in patients with scleroderma: a nested case-control study.
Pontifex EK; Hill CL; Roberts-Thomson P
Ann Rheum Dis; 2007 Apr; 66(4):551-3. PubMed ID: 16984943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
